Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ.

AIDS. 2014 Apr 24;28(7):979-87. doi: 10.1097/QAD.0000000000000167.

PMID:
24681415
[PubMed - in process]
2.

Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.

Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R; ACTG-ALLRT Protocol Team.

Oncology. 2011;80(1-2):42-9. doi: 10.1159/000328032. Epub 2011 May 23.

PMID:
21606663
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, Dittmer DP, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mayer K, Mathews WC, Hunt PW, Rodriguez B, Eron JJ.

Clin Infect Dis. 2013 Sep;57(5):756-64. doi: 10.1093/cid/cit369. Epub 2013 Jun 4.

PMID:
23735330
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group.

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4.

PMID:
22173233
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.

Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MP.

AIDS. 2013 Feb 20;27(4):645-50. doi: 10.1097/QAD.0b013e32835c12f9.

PMID:
23169326
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

JAMA. 1999 Dec 15;282(23):2220-6.

PMID:
10605973
[PubMed - indexed for MEDLINE]
7.

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, Dabis F, Wood R, Sprinz E, Schechter M, Egger M; ART-LINC Collaboration of IeDEA.

AIDS. 2008 Nov 12;22(17):2291-302. doi: 10.1097/QAD.0b013e3283121ca9.

PMID:
18981768
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3.

PMID:
18645520
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.

Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J.

HIV Med. 2013 Jul;14(6):362-9. doi: 10.1111/hiv.12016. Epub 2013 Feb 21.

PMID:
23433434
[PubMed - indexed for MEDLINE]
10.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

PMID:
16104038
[PubMed - indexed for MEDLINE]
Free Article
11.

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Quesenberry CP Jr, Abrams DI, Silverberg MJ.

AIDS. 2012 Nov 13;26(17):2223-31. doi: 10.1097/QAD.0b013e32835935b3.

PMID:
22951631
[PubMed - indexed for MEDLINE]
12.

[Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].

Ding YY, Jia WQ, Wang JS, Dong SL, Yang QH, Zhou RY, Qu SX, Lu LX, Wei J, Qiao XC, Gao MY, Guo XL, Zhang TJ, Wu ZY, He N.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Dec;29(12):1176-80. Chinese.

PMID:
19173958
[PubMed - indexed for MEDLINE]
13.

Association of early HIV viremia with mortality after HIV-associated lymphoma.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ.

AIDS. 2013 Sep 24;27(15):2365-73. doi: 10.1097/QAD.0b013e3283635232.

PMID:
23736149
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.

Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D; STOPAR study team.

Antivir Ther. 2013;18(1):125-30. doi: 10.3851/IMP2249. Epub 2012 Jul 18.

PMID:
22805174
[PubMed - indexed for MEDLINE]
15.

Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Balestre E, Eholié SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiébaut R; International epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

AIDS. 2012 May 15;26(8):951-7. doi: 10.1097/QAD.0b013e3283528ad4.

PMID:
22382142
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.

Durier N, Ananworanich J, Apornpong T, Ubolyam S, Kerr SJ, Mahanontharit A, Ferradini L, Ruxrungtham K, Avihingsanon A.

Clin Infect Dis. 2013 Jul;57(1):147-55. doi: 10.1093/cid/cit173. Epub 2013 Mar 19.

PMID:
23511301
[PubMed - indexed for MEDLINE]
Free Article
17.

Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD, Little SJ, Clark RA, He W, Ahuja SK.

JAMA Intern Med. 2015 Jan;175(1):88-99. doi: 10.1001/jamainternmed.2014.4010.

PMID:
25419650
[PubMed - in process]
18.

The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease.

Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY.

AIDS. 2012 Jun 1;26(9):1115-20. doi: 10.1097/QAD.0b013e328352ce54.

PMID:
22382147
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Chêne G, Binquet C, Moreau JF, Neau D, Pellegrin I, Malvy D, Ceccaldi J, Lacoste D, Dabis F.

AIDS. 1998 Dec 3;12(17):2313-20.

PMID:
9863874
[PubMed - indexed for MEDLINE]
20.

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C; Partners in Prevention HSV/HIV Transmission Study Team.

Lancet. 2010 Jun 12;375(9731):2092-8. doi: 10.1016/S0140-6736(10)60705-2. Epub 2010 May 26.

PMID:
20537376
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk